SYNCOM FORMULATIONS (INDIA)
Back to Balance Sheet
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2017 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹108 Cr | ₹103 Cr | ₹76 Cr | ₹68 Cr | ₹46 Cr |
What is the latest Sundry Debtors ratio of SYNCOM FORMULATIONS (INDIA) ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹108 Cr |
| Mar2024 | ₹103 Cr |
| Mar2023 | ₹76 Cr |
| Mar2022 | ₹68 Cr |
| Mar2017 | ₹46 Cr |
How is Sundry Debtors of SYNCOM FORMULATIONS (INDIA) Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹108 Cr | 4.12 | |
| Mar2024 | ₹103 Cr | 36.81 | |
| Mar2023 | ₹76 Cr | 11.78 | |
| Mar2022 | ₹68 Cr | 46.86 | |
| Mar2017 | ₹46 Cr | - | |
Compare Sundry Debtors of peers of SYNCOM FORMULATIONS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNCOM FORMULATIONS (INDIA) | ₹1,409.1 Cr | -1.2% | -5.8% | -33.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹428,581.0 Cr | -1.6% | 4.6% | -0.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,051.0 Cr | -2.5% | -6% | 3.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹128,367.0 Cr | 1.2% | -1.4% | 11.8% | Stock Analytics | |
| CIPLA | ₹120,289.0 Cr | -1.2% | -1.5% | -0.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,421.0 Cr | -2.7% | 4% | 2.2% | Stock Analytics | |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNCOM FORMULATIONS (INDIA) | -1.2% |
-5.8% |
-33.3% |
| SENSEX | -0.8% |
1% |
3.2% |
You may also like the below Video Courses